Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase NA 1Phase 3 1Phase 2 1

Status

Completed 3Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 9INDUSTRY 5NIH 1NETWORK 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 5

Conditions

Colorectal Neoplasms 1461Pancreatic Neoplasms 832Stomach Neoplasms 692Carcinoma, Hepatocellular 647Carcinoma, Non-Small-Cell Lung 540Neoplasms 459Breast Neoplasms 369Ovarian Neoplasms 338Neoplasm Metastasis 336Colonic Neoplasms 331Esophageal Neoplasms 297Liver Neoplasms 265Melanoma 255Lung Neoplasms 245Squamous Cell Carcinoma of Head and Neck 210Cholangiocarcinoma 180Carcinoma, Renal Cell 180Prostatic Neoplasms 175Head and Neck Neoplasms 172Triple Negative Breast Neoplasms 162Endometrial Neoplasms 160Rectal Neoplasms 159Uterine Cervical Neoplasms 155Gastrointestinal Neoplasms 142Urinary Bladder Neoplasms 139Biliary Tract Neoplasms 135Gastrointestinal Stromal Tumors 108Sarcoma 104Esophageal Squamous Cell Carcinoma 102Small Cell Lung Carcinoma 95

Interventions

Fluorouracil 3irinotecan sucrosofate 2Leucovorin 2zolbetuximab 1pembrolizumab 1beta-D-glucosylisophosphoramide mustard 1Drug Therapy 14-fluorobenzoyl-TN-14003 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
INDUSTRY × Metastatic Pancreatic Adenocarcinoma × Gastrointestinal × Clear all
NCT06396091 2025-11-13

A Study of Zolbetuximab With Chemotherapy in Adults With Pancreatic Cancer

Astellas Pharma Inc

Phase 1 Active not recruiting
12 enrolled
Gastrointestinal

Metastatic Pancreatic Adenocarcinoma

NCT05078775 2025-07-18

Medical Food for the Dietary Management of Advanced/Metastatic Pancreatic Cancer

Faeth Therapeutics

Phase NA Completed
39 enrolled
Gastrointestinal

Metastatic Pancreatic Adenocarcinoma

NCT05383352 2025-04-30

SIRACUSA

Ipsen

Phase 1 Completed
177 enrolled
Gastrointestinal

Metastatic Pancreatic Adenocarcinoma

NCT01954992 2024-12-31

Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer

Eleison Pharmaceuticals LLC.

Phase 3 Recruiting
480 enrolled
Gastrointestinal

Metastatic Pancreatic Adenocarcinoma

NCT02826486 2024-08-28

COMBAT

BioLineRx, Ltd.

Phase 2 Completed
80 enrolled 13 charts
Gastrointestinal

Metastatic Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡